Alimera Sciences (ALIM) Revenue
Market Cap: $301.29M
Avg Volume: 866.83K
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
What is Alimera Sciences's Revenue?
Alimera Sciences's quarterly revenue as of Q2 2024 is $27.00M.
Alimera Sciences's annual revenue for the fiscal year 2023 is $80.75M.
Related metrics for Alimera Sciences (quarterly):
- Cost of Revenue: $6.92M
- Gross Profit: $20.08M
- Gross Profit Ratio: 74.40%
- Revenue Per Share: $0.50
- Revenue Growth: 17.34%
Apple's quarterly revenue was $27.00M, with a cost of revenue of $6.92M, which leaves $20.08M gross profit and a gross profit ratio of 74.40%.
Related metrics for Alimera Sciences (annual):
- Cost of Revenue: $19.58M
- Gross Profit: $61.17M
- Gross Profit Ratio: 75.70%
- Revenue Per Share: $3.16
- Revenue Growth: 49.19%
Apple's annual revenue was $80.75M, with a cost of revenue of $19.58M, which leaves $61.17M gross profit and a gross profit ratio of 75.70%.
Understanding Revenue
Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations. It is often referred to as the "top line" because it sits at the top of the income statement.
End of Year Revenue
The table below shows the revenue for each fiscal year, with the latest data available for 2023.
| Year | Revenue | Change |
|---|---|---|
| 2023 | $80.75M | 49.19% |
| 2022 | $54.13M | -8.30% |
| 2021 | $59.03M | 16.15% |
| 2020 | $50.82M | -5.79% |
| 2019 | $53.94M | 14.85% |
| 2018 | $46.97M | 30.79% |
| 2017 | $35.91M | 4.60% |
| 2016 | $34.33M | 53.01% |
| 2015 | $22.44M | 166.39% |
| 2014 | $8.42M | 349.95% |
| 2013 | $1.87M | N/A |
| 2012 | $- | N/A |
| 2011 | $- | N/A |
| 2010 | $- | N/A |
| 2009 | $- | N/A |
| 2008 | $- | N/A |
| 2007 | $- | N/A |
| 2006 | $- | N/A |
Related Metrics
Explore detailed financial metrics and analysis for ALIM.